Lakshmi Rajdev, discusses the efficacy of pembrolizumab (Keytruda) plus chemotherapy in patients with esophageal cancer.
Lakshmi N. Rajdev, MD
Advertisement
Articles by Lakshmi N. Rajdev, MD
Lakshmi N. Rajdev, MD, discusses the use of somatostatin analogs in patients with neuroendocrine tumors.
Lakshmi N. Rajdev, MD, an associate professor, Department of Medicine (Oncology), at Albert Einstein College of Medicine, Montefiore Medical Center, discusses the difference between cancers and carcinomas in neuroendocrine tumors (NETs).
Advertisement
Latest Updated Articles
Dr. Rajdev on the Difference Between Cancers and Carcinomas in NETsNovember 5th 2019
Dr. Rajdev on the Use of Somatostatin Analogs in Neuroendocrine TumorsNovember 22nd 2019
Advertisement
Advertisement
Trending on OncLive
1
ctDNA Status Has Strong Prognostic Value, Outperforming pCR Status, in Early TNBC
2
From Toilet Cleaner to Thoracic Oncologist and Patient: How Ross Camidge Built a Life Worth Loving
3
The OncFive: Top Oncology Articles for the Week of 5/31
4
Breast Cancer Experts Spotlight Practice-Informing and Thought-Provoking Data From ASCO 2026
5